Your browser doesn't support javascript.
loading
Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers.
Adrielle Dos Santos, Letícia; Filho, Pedro Germano de Góis; Silva, Ana Maria Fantini; Santos, João Victor Gomes; Santos, Douglas Siqueira; Aquino, Marília Marques; de Jesus, Rafaela Mota; Almeida, Maria Luiza Dória; da Silva, João Santana; Altmann, Daniel M; Boyton, Rosemary J; Alves Dos Santos, Cliomar; Santos, Camilla Natália Oliveira; Alves, Juliana Cardoso; Santos, Ianaline Lima; Magalhães, Lucas Sousa; Belitardo, Emilia M M A; Rocha, Danilo J P G; Almeida, João P P; Pacheco, Luis G C; Aguiar, Eric R G R; Campos, Gubio Soares; Sardi, Silvia Inês; Carvalho, Rejane Hughes; de Jesus, Amélia Ribeiro; Rezende, Karla Freire; de Almeida, Roque Pacheco.
  • Adrielle Dos Santos L; Department of Medicine, Federal University of Sergipe, Immunology Investigative Institute (III), INCT, CNPq, Aracaju, Sergipe 49060-100, Brazil.
  • Filho PGG; Department of Medicine, Federal University of Sergipe, Immunology Investigative Institute (III), INCT, CNPq, Aracaju, Sergipe 49060-100, Brazil.
  • Silva AMF; Department of Medicine, Federal University of Sergipe, Immunology Investigative Institute (III), INCT, CNPq, Aracaju, Sergipe 49060-100, Brazil.
  • Santos JVG; Department of Medicine, Federal University of Sergipe, Immunology Investigative Institute (III), INCT, CNPq, Aracaju, Sergipe 49060-100, Brazil.
  • Santos DS; Department of Medicine, Federal University of Sergipe, Immunology Investigative Institute (III), INCT, CNPq, Aracaju, Sergipe 49060-100, Brazil.
  • Aquino MM; Department of Medicine, Federal University of Sergipe, Immunology Investigative Institute (III), INCT, CNPq, Aracaju, Sergipe 49060-100, Brazil.
  • de Jesus RM; Division of Pulmonology, Institute of Health Promotion and Assistance for Employees of the State of Sergipe (IPESAÚDE), Sergipe, Brazil.
  • Almeida MLD; Department of Medicine, Federal University of Sergipe, Immunology Investigative Institute (III), INCT, CNPq, Aracaju, Sergipe 49060-100, Brazil.
  • da Silva JS; Fiocruz - Bi-Institutional Translational Medicine Project, Ribeirao Preto Medical School, Department of Biochemistry and Immunology, 14049-900 Ribeirao Preto, SP, Brazil.
  • Altmann DM; Department of Immunology and Inflammation, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, W12 ONN, United Kingdom. Electronic address: d.altmann@ic.ac.uk.
  • Boyton RJ; Department of Immunology and Inflammation, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, W12 ONN, United Kingdom.
  • Alves Dos Santos C; Health Foundation Parreiras Horta, Central Laboratory of Public Health (LACEN/SE), State Secretary for Health, Sergipe, Brazil.
  • Santos CNO; Division of Immunology and Molecular Biology Laboratory, University Hospital/EBSERH, Federal University of Sergipe, Sergipe CEP 49.060-025, Brazil.
  • Alves JC; Division of Immunology and Molecular Biology Laboratory, University Hospital/EBSERH, Federal University of Sergipe, Sergipe CEP 49.060-025, Brazil.
  • Santos IL; Division of Immunology and Molecular Biology Laboratory, University Hospital/EBSERH, Federal University of Sergipe, Sergipe CEP 49.060-025, Brazil.
  • Magalhães LS; Division of Immunology and Molecular Biology Laboratory, University Hospital/EBSERH, Federal University of Sergipe, Sergipe CEP 49.060-025, Brazil.
  • Belitardo EMMA; Institute of Health Sciences, Federal University of Bahia, Salvador-BA, Brazil.
  • Rocha DJPG; Institute of Health Sciences, Federal University of Bahia, Salvador-BA, Brazil.
  • Almeida JPP; Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte-MG, Brazil.
  • Pacheco LGC; Institute of Health Sciences, Federal University of Bahia, Salvador-BA, Brazil.
  • Aguiar ERGR; Department of Biological Sciences, Center of Biotechnology and Genetics, State University of Santa Cruz (UESC), Ilhéus-BA, Brazil.
  • Campos GS; Virology Laboratory, Institute of Health Sciences, Federal University of Bahia, Salvador-BA, Brazil.
  • Sardi SI; Virology Laboratory, Institute of Health Sciences, Federal University of Bahia, Salvador-BA, Brazil.
  • Carvalho RH; Virology Laboratory, Institute of Health Sciences, Federal University of Bahia, Salvador-BA, Brazil.
  • de Jesus AR; Department of Medicine, Federal University of Sergipe, Immunology Investigative Institute (III), INCT, CNPq, Aracaju, Sergipe 49060-100, Brazil; Division of Immunology and Molecular Biology Laboratory, University Hospital/EBSERH, Federal University of Sergipe, Sergipe CEP 49.060-025, Brazil.
  • Rezende KF; Department of Medicine, Federal University of Sergipe, Immunology Investigative Institute (III), INCT, CNPq, Aracaju, Sergipe 49060-100, Brazil.
  • de Almeida RP; Department of Medicine, Federal University of Sergipe, Immunology Investigative Institute (III), INCT, CNPq, Aracaju, Sergipe 49060-100, Brazil; Division of Immunology and Molecular Biology Laboratory, University Hospital/EBSERH, Federal University of Sergipe, Sergipe CEP 49.060-025, Brazil. Electro
J Infect ; 82(3): 399-406, 2021 03.
Article en En | MEDLINE | ID: mdl-33589297
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Personal de Salud / Reinfección / COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans País como asunto: America do sul / Brasil Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Personal de Salud / Reinfección / COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans País como asunto: America do sul / Brasil Idioma: En Año: 2021 Tipo del documento: Article